Approvals/TGA/MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial

Approved

STANDARD

MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f1ab6c03aa33db70
Product Name: MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial
Artg Id: 116622
Artg Name: MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2006-05-10
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/89d5cfa69b8d16afa7fe11280524a9d0.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ce0addbe386ea0433428d421e338a8e8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

f1ab6c03aa33db70

Type

Standard